Literature DB >> 10389671

Clinical rationale for very-high-field (3.0 Tesla) functional magnetic resonance imaging.

K R Thulborn1.   

Abstract

The recent development of integrating very-high-field magnets (3.0 T) into clinical scanners was driven by the demonstration that both functional and anatomic information can be derived reliably at high spatial and temporal resolution. As very-high-field magnetic resonance imaging now approaches its entry into the clinical arena with a product by one major scanner manufacturer that is to be considered for Food and Drug Administration clearance, it is timely to consider the clinical applications that are likely to make such new technology significant in medical imaging. The rationale for very high field is based on the mechanism of blood oxygenation level-dependent contrast and the need for reliable functional studies on individual patients. The use of functional magnetic resonance imaging in the setting of presurgical planning is demonstrated in a number of different clinical scenarios. Such cases covering both pediatric and adult patients indicate that 3.0-T functional magnetic resonance imaging has an important role in neuroradiology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10389671     DOI: 10.1097/00002142-199902000-00004

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  9 in total

1.  Reliability of a new adjustable shunt device without the need for readjustment following 3-Tesla MRI.

Authors:  Wolf Lüdemann; Steffen K Rosahl; Jan Kaminsky; Madjid Samii
Journal:  Childs Nerv Syst       Date:  2005-01-19       Impact factor: 1.475

Review 2.  The optimal use of contrast agents at high field MRI.

Authors:  Siegfried Trattnig; Kathia Pinker; Ahmed Ba-Ssalamah; Iris-Melanie Nöbauer-Huhmann
Journal:  Eur Radiol       Date:  2006-03-01       Impact factor: 5.315

3.  Intraindividual comparison of myocardial delayed enhancement MR imaging using gadobenate dimeglumine at 1.5 T and 3 T.

Authors:  Bernhard D Klumpp; Joern Sandstede; Klaus P Lodemann; Achim Seeger; Tobias Hoevelborn; Michael Fenchel; Ulrich Kramer; Claus D Claussen; Stephan Miller
Journal:  Eur Radiol       Date:  2008-12-18       Impact factor: 5.315

4.  Direct visualization of the human subthalamic nucleus with 3T MR imaging.

Authors:  K V Slavin; K R Thulborn; C Wess; H Nersesyan
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

Review 5.  MRI evaluation and safety in the developing brain.

Authors:  Shannon Tocchio; Beth Kline-Fath; Emanuel Kanal; Vincent J Schmithorst; Ashok Panigrahy
Journal:  Semin Perinatol       Date:  2015-03-03       Impact factor: 3.300

Review 6.  Quantitative sodium MR imaging: A review of its evolving role in medicine.

Authors:  Keith R Thulborn
Journal:  Neuroimage       Date:  2016-11-24       Impact factor: 6.556

7.  Vascular perfusion of choroidal melanoma by 3.0 tesla magnetic resonance imaging.

Authors:  Bruce M Buerk; Jose S Pulido; Ignacio Chiong; Robert Folberg; Deepak P Edward; Mark T Duffy; Keith R Thulborn
Journal:  Trans Am Ophthalmol Soc       Date:  2004

8.  Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.

Authors:  Keith R Thulborn; Aiming Lu; Ian C Atkinson; Mohan Pauliah; Kathryn Beal; Timothy A Chan; Antonio Omuro; Josh Yamada; Michelle S Bradbury
Journal:  Clin Cancer Res       Date:  2018-11-28       Impact factor: 12.531

9.  [Use of contrast agent in high-field MRI (3 T)].

Authors:  S Trattnig; A Ba-Ssalamah; I M Nöbauer-Huhmann; M Barth; K Pinker; V Mlynarik
Journal:  Radiologe       Date:  2004-01       Impact factor: 0.635

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.